Merck & Co., Inc. (MRK)

USD 98.34

(-1.72%)

Total Assets Summary of Merck & Co., Inc.

  • Merck & Co., Inc.'s latest annual total assets in 2023 was 106.67 Billion USD , down -2.28% from previous year.
  • Merck & Co., Inc.'s latest quarterly total assets in 2024 Q2 was 112.63 Billion USD , up 6.41% from previous quarter.
  • Merck & Co., Inc. reported annual total assets of 109.16 Billion USD in 2022, up 3.28% from previous year.
  • Merck & Co., Inc. reported annual total assets of 105.69 Billion USD in 2021, up 15.4% from previous year.
  • Merck & Co., Inc. reported quarterly total assets of 112.63 Billion USD for 2024 Q2, up 6.41% from previous quarter.
  • Merck & Co., Inc. reported quarterly total assets of 107.79 Billion USD for 2023 Q1, down -1.25% from previous quarter.

Annual Total Assets Chart of Merck & Co., Inc. (2023 - 1989)

Historical Annual Total Assets of Merck & Co., Inc. (2023 - 1989)

Year Total Assets Total Assets Growth
2023 106.67 Billion USD -2.28%
2022 109.16 Billion USD 3.28%
2021 105.69 Billion USD 15.4%
2020 91.58 Billion USD 8.52%
2019 84.39 Billion USD 2.13%
2018 82.63 Billion USD -5.96%
2017 87.87 Billion USD -7.87%
2016 95.37 Billion USD -6.29%
2015 101.77 Billion USD 3.5%
2014 98.33 Billion USD -6.92%
2013 105.64 Billion USD -0.46%
2012 106.13 Billion USD 0.96%
2011 105.12 Billion USD -0.62%
2010 105.78 Billion USD -5.63%
2009 112.08 Billion USD 137.5%
2008 47.19 Billion USD -2.39%
2007 48.35 Billion USD 8.48%
2006 44.56 Billion USD -0.62%
2005 44.84 Billion USD 5.34%
2004 42.57 Billion USD 4.89%
2003 40.58 Billion USD -14.66%
2002 47.56 Billion USD 8.08%
2001 44 Billion USD 10.26%
2000 39.91 Billion USD 12.0%
1999 35.63 Billion USD 11.87%
1998 31.85 Billion USD 23.41%
1997 25.81 Billion USD 6.25%
1996 24.29 Billion USD 1.94%
1995 23.83 Billion USD 9.04%
1994 21.85 Billion USD 9.68%
1993 19.92 Billion USD 79.75%
1992 11.08 Billion USD 16.71%
1991 9.49 Billion USD 18.29%
1990 8.02 Billion USD 18.84%
1989 6.75 Billion USD 10.27%

Peer Total Assets Comparison of Merck & Co., Inc.

Name Total Assets Total Assets Difference
AbbVie Inc. 134.71 Billion USD 20.812%
Bristol-Myers Squibb Company 95.15 Billion USD -12.102%
Bristol-Myers Squibb Company Ce 95.15 Billion USD -12.102%
Johnson & Johnson 167.55 Billion USD 36.335%
Eli Lilly and Company 64 Billion USD -66.663%
Novartis AG 99.94 Billion USD -6.734%
Organon & Co. 12.05 Billion USD -784.682%
Pfizer Inc. 226.5 Billion USD 52.903%